Renaissance Technologies
DCPH

Renaissance Technologies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Renaissance Technologies’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-530,200
Closed -$8.34M – 4078
2024
Q1 		$8.34M Buy
530,200
+92,900
+21% +$1.43M 0.01% 1095
2023
Q4 		$7.05M Buy
437,300
+125,900
+40% +$1.61M 0.01% 1130
2023
Q3 		$3.96M Buy
311,400
+190,800
+158% +$2.63M 0.01% 1434
2023
Q2 		$1.7M Sell
120,600
-110,718
-48% -$1.58M ﹤0.01% 2100
2023
Q1 		$3.57M Buy
231,318
+140,618
+155% +$2.35M ﹤0.01% 1677
2022
Q4 		$1.49M Buy
+90,700
New +$1.47M ﹤0.01% 2270
2022
Q3 		– Sell
-88,900
Closed -$1.17M – 4511
2022
Q2 		$1.17M Buy
+88,900
New +$981K ﹤0.01% 2605
2021
Q4 		– Sell
-34,800
Closed -$1.18M – 4301
2021
Q3 		$1.18M Buy
+34,800
New +$1.11M ﹤0.01% 2457
2020
Q2 		– Sell
-418,600
Closed -$17.2M – 3836
2020
Q1 		$17.2M Buy
418,600
+204,000
+95% +$11.3M 0.02% 853
2019
Q4 		$13.4M Buy
214,600
+70,900
+49% +$3.37M 0.01% 1261
2019
Q3 		$4.88M Buy
+143,700
New +$4.25M ﹤0.01% 1811

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Renaissance Technologies's DCPH Position: Q2 2024 in Review

Renaissance Technologies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 530,200 shares — an estimated $8.34M sold.

Renaissance Technologies first reported a position in DCPH in Q3 2019 and held it in 11 quarters. The position peaked at $17.2M in Q1 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Renaissance Technologies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 530,200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $8.34M.
  • Renaissance Technologies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Renaissance Technologies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $17.2M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.